Overview:
IGB offers oncomine next-generation sequencing (NGS) solutions for liquid biopsy research can provide detailed insights with precision and speed, from just a single tube of blood. Oncomine Cell-Free Nucleic Acid (cfNA) liquid biopsy assays are highly sensitive, multi-biomarker NGS assays that enable molecular insights into tumor evolution and detection of primary driver and resistance mutations for clinical research. With a single tube of blood, you can go from sample to complete variant report in days, not weeks. Oncomine cfNA assays enable you to deliver a relevant genomic profile even if a tissue sample is unavailable, or complement tissue testing to understand tumor heterogeneity.
Assay Options:
Oncomine Solutions
Solid Tumor Genomics Profiling - Liquid Biopsy
